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Chlorotetracycline has been used in human polymorphonuclear leukocytes as a probe to investigate the state of membrane-bound calcium. We 
examined the effect of adenosine on the fluorescence responses of CTC-loaded PMNs stimulated with the synthetic hemotactic peptide, formyl- 
methionyl-leucyl-phenylalanine. Adenosine inhibited the decrease in CTC fluorescence in a dose-dependent fashion and its effect was reversed by 
theophylline, an adenosine receptor antagonist. Removal of extracellular adenosine by incubating PMNs with adenosine deaminase abolished the 
effect of adenosine. These data suggest hat adenosine inhibits the release of membrane-bound calcium in PMNs that normally occurs in response 
to chemotactic stimuli, acting via PMN surface adenosine receptors. 
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1. INTRODUCTION 
Adenosine modulates a variety of human polymor- 
phonuclear leukocyte (PMN) functions such as 
superoxide generation in response to several stimuli ac- 
ting via PMN surface adenosine A2 receptors [l-6], 
but its mechanism of action remains unclear. 
Adenosine inhibits superoxide generation by PMNs in 
response to stimuli which cause a rise in the in- 
tracellular free calcium concentration, such as formyl- 
methionyl-leucyl-phenylalanine (FMLP) or the calcium 
ionophore A23187. However, it has little effect when 
PMNs are stimulated with phorbol myristate acetate 
(PMA) or latex beads, which activate the cells indepen- 
dent of a rise in intracellular free calcium [1,3]. Thus, 
there is a possibility that adenosine modulates PMN 
functions through interacting with the intracellular 
calcium homeostasis. However, adenosine seems to 
have little effect on the intracellular free calcium level 
in PMNs as determined by fluorescence changes of 
fura- or quin-2 [5,7], and its effect on calcium 
mobilization has not been elucidated. 
[ 1 l- 141. We investigated the effect of adenosine and its 
analogues on fluorescence changes of CTC-loaded 
human PMNs stimulated with the synthetic chemotac- 
tic peptide, FMLP, to determine the role of the regula- 
tion of membrane-bound calcium in the inhibitory 
action of adenosine on PMN functions. 
2. MATERIALS AND METHODS 
2.1. Materials 
Chlorotetracycline, adenosine, 2-chloroadenosine, L- 
N6-phenylisopropyladenosine (PIA), theophylline, hypoxanthine, in- 
osine and FMLP were obtained from Sigma Chemical Co. 5’-N- 
ethylcarboxamideadenosine (NECA) and adenosine deaminase 
(ADA) from calf intestines were purchased from Boehringer Mann- 
heim Biochemicals. Yamasa Shoyu Co. kindly provided the 
2’-deoxycoformycin (dCF). 
2.2. PMN preparation 
Heparinized venous blood was obtained from healthy adult 
donors. PMNs were isolated by dextran sedimentation followed by 
centrifugation on Ficoll-Hypaque gradients [15], and contaminating 
erythrocytes were lysed by hypotonic saline. PMNs were washed 
twice and suspended in Hanks’ balanced salt solution (HBSS). 
Chlorotetracycline (CTC) is another fluorescent pro- 
be for intracellular calcium, which is considered to 
reflect the state of membrane-bound calcium [g-lo]. 
The fluorescence from CTC-loaded PMNs decreases 
upon stimulation, and these decreases are considered to 
be due to the release of membrane-bound calcium 
2.3. Measurement of CTC fluorescence 
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CTC loading was performed according to the method of Smolen 
et al. [14]. In brief, PMNs were suspended at 1 x lO’/ml in calcium- 
containing HBSS and incubated with 50pM CTC at 37°C for 
20 min. Then cells were washed once with the buffer and kept at 
room temperature until used. Two ml of PMN suspension in HBSS 
containing 5 x lo6 PMNs were placed in a thermostatically controlled 
(37°C) cuvette in a fluorescence spectrofluorometer (Model RF-510, 
Shimadzu). The cells were maintained in suspension with a magnetic 
stirrer, underwent excitation at 380 nm, and emission signals were 
recorded at 560 nm. 
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3. RESULTS 
3.1. Inhibition by adenosine of the decrease of CTC 
ji’uorescence in PMN stimulated with FMLP 
Fig. 1 shows typical tracings of the CTC fluorescence 
from PMNs stimulated with 0.1 ,uM FMLP with or 
without 1 PM adenosine. When stimulated with FMLP, 
the fluorescence from CTC-loaded PMNs decreased 
rapidly, and the maximal decrease was observed at 
45-60 s after stimulation. This decrease of CTC 
fluorescence was inhibited when PMNs were prein- 
cubated with adenosine for 15 min at 37°C. Fig. 2 
shows the dose-response data for adenosine. Adenosine 
inhibited the decrease of CTC fluorescence in a dose- 
dependent fashion and inhibition was significant at 
doses as low as 0.01 PM. 
3.2. Effect of theophylline 
Fig. 3 shows the effect of theophylline, a known 
adenosine receptor antagonist. When lo-100 PM 
theophylline was added together with adenosine, the in- 
hibitory effect of 0.1 pM adenosine was reversed. 
These results are consistent with the hypothesis that 
adenosine binds with adenosine receptors to inhibit the 
decrease of CTC fluorescence. 
3.3. Effects of adenosine metabolites 
To determine the possible role of adenosine 
metabolites, we investigated the effect of an ADA in- 
hibitor (2 ’ -deoxycoformycin; dCF) on the changes in 
CTC fluorescence produced by adenosine. The effect 
of adenosine was slightly reversed by the addition of 
dCF, but this change was not statistically significant. 
The major metabolites of adenosine deamination, in- 
osine and hypoxanthine, did not inhibit the decrease in 
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Fig. 1. Typical tracings of the changes in CTC fluorescence with or 
without 1 PM adenosine. PMNs were stimulated with lo-’ M FMLP 
at the indicated time. The right tracing shows the result when PMNs 
were preincubated with 1 pM adenosine at 37’C for 15 min before 
stimulation. Adenosine inhibited the decrease in fluorescence in 
CTC-loaded PMNs. 
contml 0.01 PM 0.1 pM 1 IJM 
Adenosine Concentration 
10pM 
Fig. 2. The dose-response data for the effect of adenosine on the 
decrease in CTC fluorescence of PMNs stimulated with lo-’ M 
FMLP. PMNs were preincubated with various concentrations of 
adenosine at 37°C for 15 min before stimulation. Values represent 
the mean f SD of three determinations. * Significantly lower than 
control, P < 0.01 by Student’s f-test. 
CTC fluorescence even at as high a concentration as 
100 PM (Table I). Furthermore, 2-chloroadenosine, a 
poorly metabolizable analogue of adenosine, inhibited 
the decrease in CTC fluorescence as potently as 
adenosine (data not shown). These results showed that 
adenosine deamination by ADA was not required for 
inhibition of the decrease in CTC fluorescence. 
3.4. Effect of ADA 
The results shown above indicated that the effect of 
adenosine on CTC fluorescence was mediated via sur- 
Control Adetxwine AdSllWiw+ AdWDSim+ 
0.1 pM Theophylline llwophylline 
1OpM 1OOpM 
Fig. 3. The effect of theophylline, an adenosine receptor antagonist. 
PMNs were incubated with 0.1 PM adenosine alone or with 
adenosine plus 10 or 1OOrM theophylline at 37°C for 15 min, and 
then stimulated with 10e7 M FMLP. Theophylhne reversed the effect 
of adenosine. Values represent the mean + SD from three 
determinations. * P < 0.01 vs 0.1 PM adenosine. 
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Table I 
Treatment Decrease in CTC fluor- 
escence (% control) 
1 yM adenosine 45.4 + 6.6 (P < o.ol)* 
1 PM adenosine + 5 @M dCF 52.6 k 4.5 (P < O.Ol)*‘** 
100 PM inosine 95.4 + 3.5 (N.S.) 
100 PM hypoxanthine 101.0 f 3.1 (N.S.) 
2’-Deoxycoformycin (dCF), an ADA inhibitor, was added 10 min 
before adenosine. dCF did not reverse the inhibitory effect of 
adenosine significantly. Inosine and hypoxanthine, even at high 
concentrations, did not inhibit the decrease in CTC fluorescence 
caused by stimulation of PMNs with FMLP. Values represent he 
mean f SD from three determinations. **** Significantly lower than 
the control (Student’s r-test). ** Not significantly different from 
1 ,uM adenosine. N.S., not significant vs control 
face adenosine receptors. When extracellular adenosine 
was removed by incubating the PMNs with ADA 
(0.25 U/ml), not only was the effect of adenosine 
abolished but also the decrease in CTC fluorescence 
was augmented (Fig. 4). This augmentation was also 
observed when ADA was added without adenosine. 
These results suggested that extracellular adenosine 
molecules were required for adenosine to have any ef- 
fect on CTC fluorescence, and that the amount of en- 
dogenously produced adenosine present in our 
experimental system was also sufficient to inhibit the 
decrease of CTC fluorescence. In fact, Cronstein et al. 
[l] have reported that supernatants of PMN suspen- 
sions may contain significant amounts of endogenous 
adenosine, and ADA treatment has been reported to 
augment some PMN functions [1,7] perhaps by the 
removal of endogenous adenosine. 
Control Adenosine Adencdne 
+ADA 
ADA 
Fig. 4. PMNs were incubated with 1 PM adenosine, 1 PM adenosine 
plus 0.25 U/ml of ADA, or 0.25 U/ml of ADA alone at 37°C for 
15 min before stimulation with lo-’ M FMLP. ADA treatment not 
only abolished the inhibitory effect of adenosine, but actually 
augmented the decrease in CTC fluorescence stimulated by 10e7 M 
FMLP. * P < 0.01, significantly lower than control; ** P < 0.01, 
significantly higher than control. 
n NECA 
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Fig. 5. The effect of NECA and PIA on the change in CTC 
fluorescence. Each adenosine analogue was added 15 min before 
stimulation at the indicated concentration and their effects on CTC 
fluorescence were compared. Mean f SD of three determinations. 
* Significantly lower than PIA, P < 0.05. 
3 S. Characterization of adenosine receptors 
NECA and PIA are adenosine analogues with dif- 
ferent affinities for adenosine Ar and A2 receptors. 
They were both effective in inhibiting the decrease in 
CTC fluorescence, with NECA being more effective 
than PIA (Fig. 5). This order of potency is 
characteristic for adenosine AZ receptors, as previously 
reported [16,17]. 
4. DISCUSSION 
Adenosine appears to inhibit PMN functions only in 
response to those stimuli which are dependent on a rise 
in the intracellular free calcium concentration [1,3]. 
Therefore, several investigators examined the effect of 
adenosine on calcium mobilization, but found that it 
seemed to have little effect on intracellular free calcium 
levels as determined by the fluorescence calcium in- 
dicators, quin-2 or fura- [5,7]. 
The release of membrane-bound calcium is one of 
the earliest events after PMN stimulation and is 
thought to be important in PMN signal transduction 
[l l-141. CTC has previously been used as a probe for 
membrane-bound calcium [8-lo], so we utilized it to 
investigate the effects of adenosine and its analogues on 
the stimulation of PMNs by the synthetic chemoattrac- 
tant, FMLP. Adenosine inhibited the decrease in 
fluorescence of CTC-loaded human PMNs in response 
to FMLP in a dose-dependent fashion. The effect of 
adenosine was reversed by theophylline, which is a po- 
tent adenosine receptor antagonist. Adenosine 
metabolites produced by ADA had little effect on the 
decrease in CTC fluorescence and an ADA inhibitor 
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could not reverse the effect of adenosine significantly. 
However, removal of extracellular adenosine by ADA 
both abolished the effect of adenosine and augmented 
the decrease in CTC fluorescence, indicating that ex- 
tracellular adenosine is required to inhibit the change in 
fluorescence. Also, NECA was more potent than PIA 
in inhibiting the decrease in CTC fluorescence, sug- 
gesting that adenosine AZ receptors were involved in 
this process. 
The results shown above indicate that physiological 
concentrations of adenosine inhibit the release of 
membrane-bound calcium in PMNs stimulated with 
FMLP, acting via surface adenosine A2 receptors. 
Therefore, it is possible that the inhibitory effects of 
adenosine on PMN functions may be caused by block- 
ing the release of membrane-bound calcium that nor- 
mally follows PMN stimulation. 
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